Genzyme

CEREZYME

Manufacturer:

Genzyme

Cerezyme HCPCS:

J1786

HCPCS Code Descriptor:

Injection, imiglucerase, 10 units

Category:

J Code

Cerezyme NDCs:

58468-4663-01

Primary Type:

Enzyme Replacement Therapy

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Cerezyme:

CEREZYME is an Enzyme Replacement Therapy drug manufactured by Genzyme and administered via the Intravenous route of administration. The J Code: J1786 is aligned to the drug CEREZYME.

ACCESS PRICING AND MORE BY REGISTERING

J1786 Added Date:

January 1, 2011

J1786 Effective Date:

January 1, 2011

J1786 Termination Date:

HCPCS Active

Cerezyme billing and coding information can be found through Genzyme at the link below:
Cerezyme patient assistance information can be found through CareconnectPSS at the URL: https://www.cerezyme.com/access-copay-assistance
CEREZYME prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for CEREZYME. Please check back in a few weeks.